EW — Edwards Lifesciences Corp · P/E 47, rev $3.39B

Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.

Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.

Use this EW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the EW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the EW SEC filings page. Lician reads the product cache first so this HTML stays unique to Edwards Lifesciences Corp even when a live quote feed is slow.

Edwards Lifesciences Corp latest statements (FY2025)

Latest cached year on this hub. Full EW income, balance, and cash tables.

  • Revenue$6.07B
  • Net Income$1.07B
  • Total Assets$13.70B
  • Total Debt$0
  • Free Cash Flow$1.86B

EW recent filings